https://mindmedicinelaw.com/briefing/psychedelics-in-psychiatry-lessons-from-intranasal-esketamine-20260828-36880The Psychedelic Journalen2026-08-30T15:05:24.061161+00:00Psychedelics in Psychiatry: Lessons from Intranasal Esketaminepsychedelics in psychiatry, intranasal esketamine, psychedelic therapies, mental disorders treatment, clinical trials, neuroscience, psychedelic safety, psychedelic commercializationhttps://mindmedicinelaw.com/briefing/ect-s-impact-on-brain-networks-insights-for-psychedelic-research-20260828-36925The Psychedelic Journalen2026-08-30T15:05:14.401858+00:00ECT's Impact on Brain Networks: Insights for Psychedelic Researchelectroconvulsive therapy, brain networks, synaptic plasticity, depression treatment, psychedelic therapy, functional connectivity, neurotransmission, neurotrophic factors, inflammatory responses, mental health researchhttps://mindmedicinelaw.com/briefing/rna-sequencing-in-depressive-disorders-progress-and-challenges-20260828-36927The Psychedelic Journalen2026-08-30T15:05:06.245275+00:00RNA Sequencing in Depressive Disorders: Progress and ChallengesRNA sequencing, depressive disorders, precision medicine, molecular mechanisms, clinical translation, data heterogeneity, single-cell transcriptomics, immune-inflammatory activation, personalized treatment, neuroendocrine-immune interactionhttps://mindmedicinelaw.com/briefing/lc-ms-ms-hair-analysis-reveals-drug-use-trends-at-brazilian-festivals-20260828-36938The Psychedelic Journalen2026-08-30T15:04:56.877200+00:00LC-MS/MS Hair Analysis Reveals Drug Use Trends at Brazilian FestivalsLC-MS/MS hair analysis, drug use patterns, electronic dance music festivals, polysubstance use, public health strategies, Brazilhttps://mindmedicinelaw.com/briefing/interoceptive-interventions-and-anxiety-sensitivity-a-review-20260828-36881The Psychedelic Journalen2026-08-30T15:04:47.185239+00:00Interoceptive Interventions and Anxiety Sensitivity: A Reviewinteroceptive interventions, anxiety sensitivity, mindfulness, cognitive behavioral therapy, occupational therapy, public health, mental health, systematic review, neuroscience, clinical trialshttps://mindmedicinelaw.com/briefing/natural-medicines-neurogenesis-depression-treatment-review-20260828-36882The Psychedelic Journalen2026-08-30T15:04:36.976182+00:00Natural Medicines & Neurogenesis: Depression Treatment Reviewnatural medicines, neurogenesis, depression treatment, major depressive disorder, clinical trials, biomarker-stratified trials, safety assessment, brain-derived neurotrophic factor, adjunctive therapies, phytochemicalshttps://mindmedicinelaw.com/briefing/lipid-metabolism-s-role-in-fluoxetine-s-efficacy-for-trd-20260828-36924The Psychedelic Journalen2026-08-30T15:04:28.627047+00:00Lipid Metabolism's Role in Fluoxetine's Efficacy for TRDlipid metabolism, fluoxetine, immunomodulatory effects, treatment-resistant depression, macrophages, LDLR pathway, antidepressant efficacy, lipid landscape, metabolic disruptionshttps://mindmedicinelaw.com/briefing/psilocybin-in-treatment-resistant-depression-emerging-evidence-20260827-36576The Psychedelic Journalen2026-08-29T15:05:11.596575+00:00Psilocybin in Treatment-Resistant Depression: Emerging Evidencepsilocybin, treatment-resistant depression, psychedelic therapy, ketamine, clinical trials, FDA, neuroscience, mental health, serotonin receptors, psychiatric carehttps://mindmedicinelaw.com/briefing/japanese-versions-of-meq-4-and-ceq-7-enhance-psychedelic-research-20260827-36580The Psychedelic Journalen2026-08-29T15:05:01.359080+00:00Japanese Versions of MEQ-4 and CEQ-7 Enhance Psychedelic ResearchJapanese MEQ-4, Japanese CEQ-7, psychedelic research Japan, mystical experiences, challenging experiences, questionnaire translation, cultural adaptation, psychedelic studies, therapeutic applications, cross-cultural researchhttps://mindmedicinelaw.com/briefing/psilocybin-enhances-sociability-in-asd-mice-without-wakefulness-20260827-36579The Psychedelic Journalen2026-08-29T15:04:45.424875+00:00Psilocybin Enhances Sociability in ASD Mice Without Wakefulnesspsilocybin, autism spectrum disorder, sociability, psychedelic therapy, serotonin receptors, neuropsychiatric conditions, clinical trials, therapeutic benefits, psychedelic effects, mouse modelhttps://mindmedicinelaw.com/briefing/ayahuasca-s-impact-on-depression-insights-from-las-vegas-study-20260827-36577The Psychedelic Journalen2026-08-29T15:04:35.016053+00:00Ayahuasca's Impact on Depression: Insights from Las Vegas Studyayahuasca, depression, prospective cohort study, Las Vegas, mental health, naturalistic use, PHQ-9, psychedelic research, observational studyhttps://mindmedicinelaw.com/briefing/beta-oscillatory-brain-state-post-psychedelic-use-insights-and-implications-20260827-36622The Psychedelic Journalen2026-08-29T15:04:24.849264+00:00Beta Oscillatory Brain State Post-Psychedelic Use: Insights and Implicationsbeta oscillatory brain state, psilocybin, 5-MeO-DMT, neural signature, psychedelic research, therapeutic applications, EEG, brain function, psychiatric treatment, biomarkershttps://mindmedicinelaw.com/briefing/integrating-medicinal-plants-and-spirituality-in-health-practices-20260824-36943The Psychedelic Journalen2026-08-30T15:05:32.912693+00:00Integrating Medicinal Plants and Spirituality in Health Practicesmedicinal plants, spirituality, traditional health practices, cultural contexts, integrative research, pharmacognosy, therapeutic potential, healthcare policy, ethical concerns, holistic healthcarehttps://mindmedicinelaw.com/briefing/dmt-s-chemical-structure-and-mystical-effects-an-analysis-20260823-36944The Psychedelic Journalen2026-08-30T15:05:49.830785+00:00DMT's Chemical Structure and Mystical Effects: An Analysisdmt, psychedelic research, consciousness studies, therapeutic potential, serotonin, ayahuasca, neuroscience, psychiatry, chemical structure, subjective effectshttps://mindmedicinelaw.com/briefing/dmt-s-chemical-mysteries-and-therapeutic-potential-20260823-36945The Psychedelic Journalen2026-08-30T15:05:42.440968+00:00DMT's Chemical Mysteries and Therapeutic PotentialDMT, psychoactive substances, ayahuasca, serotonin, brain connectivity, psychiatric therapy, consciousness, Indigenous practices, pharmacology, neurosciencehttps://mindmedicinelaw.com/briefing/ketamine-and-esketamine-in-post-op-pain-new-insights-20260818-36662The Psychedelic Journalen2026-08-29T15:04:52.810594+00:00Ketamine and Esketamine in Post-Op Pain: New Insightsketamine, esketamine, postoperative pain, gynecological surgery, analgesia, clinical trials, pain management, opioid alternatives, NMDA receptor antagonists, psychedelics